Frank Grollman

470 total citations
12 papers, 390 citations indexed

About

Frank Grollman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Frank Grollman has authored 12 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Frank Grollman's work include Immunotherapy and Immune Responses (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Frank Grollman is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Frank Grollman collaborates with scholars based in United States. Frank Grollman's co-authors include Jean L. Grem, J. Michael Hamilton, Chris H. Takimoto, Richard H. Wilson, Éva Szabó, Rebecca R. Thomas, Len Neckers, Louise B. Grochow, Carmen J. Allegra and Nancy Harold and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Translational Medicine.

In The Last Decade

Frank Grollman

12 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Grollman United States	6	256	166	58	49	29	12	390
John-Paul Jimenez United States	6	335 1.3×	75 0.5×	60 1.0×	48 1.0×	57 2.0×	8	381
Masaki Gouda Japan	9	235 0.9×	85 0.5×	28 0.5×	52 1.1×	42 1.4×	11	385
Hung Kam Cheung United States	8	248 1.0×	224 1.3×	101 1.7×	58 1.2×	30 1.0×	11	466
Vojo Vukovic United States	7	277 1.1×	125 0.8×	54 0.9×	99 2.0×	24 0.8×	13	440
Jinrong Cheng United States	7	261 1.0×	78 0.5×	71 1.2×	63 1.3×	28 1.0×	14	350
James H. Ahn United States	7	397 1.6×	80 0.5×	69 1.2×	29 0.6×	49 1.7×	8	536
Brian Zifcak United States	7	431 1.7×	136 0.8×	43 0.7×	45 0.9×	17 0.6×	10	570
Heinrich Baust Germany	9	199 0.8×	121 0.7×	29 0.5×	36 0.7×	21 0.7×	11	353
W. Roy Smythe United States	13	351 1.4×	136 0.8×	34 0.6×	145 3.0×	28 1.0×	21	567
Tahir Sheikh United States	8	335 1.3×	162 1.0×	35 0.6×	48 1.0×	62 2.1×	19	431

Countries citing papers authored by Frank Grollman

Since Specialization

Citations

This map shows the geographic impact of Frank Grollman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Grollman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Grollman more than expected).

Fields of papers citing papers by Frank Grollman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Grollman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Grollman. The network helps show where Frank Grollman may publish in the future.

Co-authorship network of co-authors of Frank Grollman

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Grollman. A scholar is included among the top collaborators of Frank Grollman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Grollman. Frank Grollman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rahma, Osama E., Ramy Ibrahim, Antoun Toubaji, et al.. (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma. Journal of Translational Medicine. 8(1). 8–8. 25 indexed citations

Gause, Barry L., et al.. (2007). Phase II clinical trial of mutant Ras peptide vaccine in combination with GM-CSF and IL-2 in advanced cancer patients. Journal of Clinical Oncology. 25(18_suppl). 3067–3067. 2 indexed citations

Gause, Barry L., Sarah Bernstein, Frank Grollman, et al.. (2005). Autologous PBMCs pulsed with HPV16 E6 as an immunotherapeutic agent for patients with advanced cervical cancer. Journal of Clinical Oncology. 23(16_suppl). 2508–2508. 3 indexed citations

Grem, Jean L., Chris H. Takimoto, Rebecca R. Thomas, et al.. (2005). Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors. Journal of Clinical Oncology. 23(9). 1885–1893. 203 indexed citations

Quinn, Mary, et al.. (2005). A phase II and pharmacologic study of fluorouracil given by a 1-hour infusion daily for 5 days with leucovorin and interferon α -2a in adenocarcinoma of the large bowel. Oncology Reports. 13(6). 1145–52. 5 indexed citations

Gause, Barry L., Susanne Steinberg, Frank Grollman, et al.. (2005). Pre-immature dendritic cells pulsed with human papillomavirus 16 E7 peptide vaccine in advanced cervical cancer. Journal of Clinical Oncology. 23(16_suppl). 2522–2522. 4 indexed citations

Harold, Nancy, Muhammad Wasif Saif, Barbara Schüler, et al.. (2003). Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule. Cancer Chemotherapy and Pharmacology. 52(1). 79–85. 13 indexed citations

Grem, Jean L., Lorrin Yee, Barbara Schüler, et al.. (2001). N-(phosphonacetyl)-l-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma. Annals of Oncology. 12(11). 1581–1587. 2 indexed citations

Grem, Jean L., Nancy Harold, Jeremy Shapiro, et al.. (2000). Phase I and Pharmacokinetic Trial of Weekly Oral Fluorouracil Given With Eniluracil and Low-Dose Leucovorin to Patients With Solid Tumors. Journal of Clinical Oncology. 18(23). 3952–3963. 20 indexed citations

10.

Shapiro, Jeremy, Nancy Harold, J. Michael Hamilton, et al.. (1999). A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.. PubMed. 5(9). 2399–408. 4 indexed citations

11.

Takimoto, Chris H., Lorrin Yee, David Venzon, et al.. (1999). High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusion.. PubMed. 5(6). 1347–52. 48 indexed citations

12.

Dahut, William L., Nancy Harold, Chris H. Takimoto, et al.. (1996). Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.. Journal of Clinical Oncology. 14(4). 1236–1244. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact